Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Repurchased (2016 - 2025)

Amphastar Pharmaceuticals has reported Shares Repurchased over the past 13 years, most recently at $20.5 million for Q4 2025.

  • Quarterly results put Shares Repurchased at $20.5 million for Q4 2025, down 51.15% from a year ago — trailing twelve months through Dec 2025 was $75.6 million (down 40.46% YoY), and the annual figure for FY2025 was $75.6 million, down 11.55%.
  • Shares Repurchased for Q4 2025 was $20.5 million at Amphastar Pharmaceuticals, up from $4.8 million in the prior quarter.
  • Over the last five years, Shares Repurchased for AMPH hit a ceiling of $50.0 million in Q3 2023 and a floor of $128000.0 in Q2 2023.
  • Median Shares Repurchased over the past 5 years was $11.0 million (2025), compared with a mean of $16.4 million.
  • Peak annual rise in Shares Repurchased hit 552.16% in 2023, while the deepest fall reached 97.91% in 2023.
  • Amphastar Pharmaceuticals' Shares Repurchased stood at $13.4 million in 2021, then soared by 34.48% to $18.1 million in 2022, then surged by 176.72% to $50.0 million in 2023, then dropped by 16.0% to $42.0 million in 2024, then crashed by 51.15% to $20.5 million in 2025.
  • The last three reported values for Shares Repurchased were $20.5 million (Q4 2025), $4.8 million (Q3 2025), and $39.2 million (Q2 2025) per Business Quant data.